Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  9, 1287 - 1292 (2003)
Published online: 21 September 2003; | doi:10.1038/nm933

Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses

Simona Stäger1, James Alexander2, Alun C Kirby1, Marina Botto3, Nico Van Rooijen4, Deborah F Smith5, Frank Brombacher6 & Paul M Kaye1

1  Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E7HT, UK.

2  Department of Immunology, Strathclyde Institute for Biomedical Sciences, University of Strathclyde, Taylor Street, Glasgow, G4 ONR,UK.

3  Rheumatology Section, Faculty of Medicine, Imperial College London, Du Cane Road, London, W12 0NN, UK.

4  Department of Molecular Cell Biology, Vrije Universiteit, Amsterdam, 1081 B5, The Netherlands.

5  Wellcome Trust Laboratories for Molecular Parasitology, Department of Biological Sciences, Imperial College London, Exhibition Road, London, SW7 2AZ, UK.

6  Department of Immunology, University of Cape Town Medical School, Groote Schuur Hospital, 7925 Cape Town, South Africa.

Correspondence should be addressed to Paul M Kaye paul.kaye@lshtm.ac.uk
CD8+ T cells are essential for long-term, vaccine-induced resistance against intracellular pathogens. Here we show that natural antibodies, acting in concert with complement, are endogenous adjuvants for the generation of protective CD8+ T cells after vaccination against visceral leishmaniasis. IL-4 was crucial for the priming of vaccine-specific CD8+ T cells, and we defined the primary source of IL-4 as a CD11b+CD11clo phagocyte. IL-4 secretion was not observed in antibody-deficient mice and could be reconstituted with serum from normal, but not Btk immune-deficient, mice. Similarly, no IL-4 response or CD8+ T-cell priming was seen in C1qa-/- mice. These results identify a new pathway by which immune complex−mediated complement activation can regulate T-cell-mediated immunity. We propose that this function of natural antibodies could be exploited when developing new vaccines for infectious diseases.

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend

Open Innovation Challenges

naturejobs

Competing financial interests
Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy